文献速递慢性肾脏病

老年晚期CKD患者肾功能下降与症状发展的关联:EQUAL队列研究

Kidney function and symptom development over time in elderly patients with advanced chronic kidney disease: results of the EQUAL cohort study.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

EQUAL前瞻性队列纳入≥65岁、肾功能降至<20 mL/min/1.73 m²的晚期CKD患者,随访1年。线性混合效应模型显示,肾功能年下降每增加1 mL/min/1.73 m²,症状数量每年多增0.23个、总体症状严重度多增0.87分;肾功能水平与症状无横断面关联。

要点

  • 肾功能年下降速度越快,症状数量与严重度增加越明显。
  • 肾功能绝对水平与症状无横断面关联,基线肾功能不预测症状发展。
  • 门诊除监测肾功能下降外,应重复全面评估症状以辅助临床决策。

核心结论

  • 更快的肾功能下降与症状数量和总体症状严重度更陡的增加相关。
  • 鉴于关联强度 modest,结果提示门诊随访中除监测肾功能下降外,重复全面评估症状对临床决策重要。

研究设计与样本

  • 欧洲前瞻性队列研究(EQUAL),纳入≥65岁、肾功能降至<20 mL/min/1.73 m²的晚期CKD患者,随访1年。
  • 采用线性混合效应模型评估肾功能下降与症状发展的关联。
  • 症状数量总分范围0–33,总体症状严重度总分范围0–165,使用透析症状指数(Dialysin Symptom Index)评估。
  • 至少有一次肾功能估计及症状数量或总体症状严重度数据的患者分别为1109例和1019例。

主要发现

  • 肾功能年均下降(95%CI)为1.70(1.32; 2.08)mL/min/1.73 m²。
  • 症状数量年均总体增加0.73(0.28; 1.19)个,总体症状严重度年均增加2.93(1.34; 4.52)分。
  • 肾功能水平与症状之间缺乏横断面关联。
  • 队列入组时肾功能与症状发展无关。
  • 肾功能年下降每1 mL/min/1.73 m²,症状数量每年额外增加0.23(0.07; 0.39)个,总体症状严重度额外增加0.87(0.35; 1.40)分。

临床怎么用

  • 对老年晚期CKD患者,除监测肾功能下降速度外,应在门诊随访中重复全面评估症状。
  • 肾功能下降较快的患者可能需更关注症状负担的增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Initiation of renal replacement therapy often results from a combination of kidney function deterioration and symptoms related to chronic kidney disease (CKD) progression. We investigated the association between kidney function decline and symptom development in patients with advanced CKD. METHODS: In the European Quality study on treatment in advanced CKD (EQUAL study), a European prospective cohort study, patients with advanced CKD aged ≥65 years and a kidney function that dropped <20 mL/min/1.73 m2 were followed for 1 year. Linear mixed-effects models were used to assess the association between kidney function decline and symptom development. The sum score for symptom number ranged from 0 to 33 and for overall symptom severity from 0 to 165, using the Dialysis Symptom Index. RESULTS: At least one kidney function estimate with symptom number or overall symptom severity was available for 1109 and 1019 patients, respectively. The mean (95% confidence interval) annual kidney function decline was 1.70 (1.32; 2.08) mL/min/1.73 m2. The mean overall increase in symptom number and severity was 0.73 (0.28; 1.19) and 2.93 (1.34; 4.52) per year, respectively. A cross-sectional association between the level of kidney function and symptoms was lacking. Furthermore, kidney function at cohort entry was not associated with symptom development. However, each mL/min/1.73 m2 of annual kidney function decline was associated with an extra annual increase of 0.23 (0.07; 0.39) in the number of symptoms and 0.87 (0.35; 1.40) in overall symptom severity. CONCLUSIONS: A faster kidney function decline was associated with a steeper increase in both symptom number and severity. Considering the modest association, our results seem to suggest that repeated thorough assessment of symptom development during outpatient clinic visits, in addition to the monitoring of kidney function decline, is important for clinical decision-making.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Janmaat CJ, van Diepen M, Meuleman Y, et al. Kidney function and symptom development over time in elderly patients with advanced chronic kidney disease: results of the EQUAL cohort study. Nephrol Dial Transplant. 2021. PMID: 31943084. doi:10.1093/ndt/gfz277

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。